- Home
- IMMP vs BSL Comparison
IMMP vs BSL Comparison
Compare IMMP & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- BSL
- Stock Information
- Founded
- IMMP 1987
- BSL 2010
- Country
- IMMP Australia
- BSL United States
- Employees
- IMMP N/A
- BSL N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- BSL Trusts Except Educational Religious and Charitable
- Sector
- IMMP Health Care
- BSL Finance
- Exchange
- IMMP Nasdaq
- BSL Nasdaq
- Market Cap
- IMMP 211.1M
- BSL 179.3M
- IPO Year
- IMMP N/A
- BSL N/A
- Fundamental
- Price
- IMMP $1.50
- BSL $13.88
- Analyst Decision
- IMMP Buy
- BSL
- Analyst Count
- IMMP 2
- BSL 0
- Target Price
- IMMP $8.50
- BSL N/A
- AVG Volume (30 Days)
- IMMP 84.6K
- BSL 71.9K
- Earning Date
- IMMP 05-02-2025
- BSL 01-01-0001
- Dividend Yield
- IMMP N/A
- BSL 9.55%
- EPS Growth
- IMMP N/A
- BSL N/A
- EPS
- IMMP N/A
- BSL N/A
- Revenue
- IMMP $3,019,249.00
- BSL N/A
- Revenue This Year
- IMMP N/A
- BSL N/A
- Revenue Next Year
- IMMP $20.28
- BSL N/A
- P/E Ratio
- IMMP N/A
- BSL N/A
- Revenue Growth
- IMMP 24.11
- BSL N/A
- 52 Week Low
- IMMP $1.32
- BSL $12.19
- 52 Week High
- IMMP $3.34
- BSL $14.56
- Technical
- Relative Strength Index (RSI)
- IMMP 39.93
- BSL 46.28
- Support Level
- IMMP $1.44
- BSL $13.72
- Resistance Level
- IMMP $1.56
- BSL $14.09
- Average True Range (ATR)
- IMMP 0.12
- BSL 0.30
- MACD
- IMMP 0.00
- BSL -0.00
- Stochastic Oscillator
- IMMP 41.63
- BSL 53.25
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.